儿童特发性关节炎与巨噬细胞活化综合征.pdf

24 第24卷第2l期2009年11月J铆，c啦砖咖打．VoLNo．21．Nov．2009 ·1631· witIlrimximabin withrheumatoidarthritis MetoA．2005，90(6)：3505—3509， targetedtherapy patients a1．Methotrexateinresistant [10]GianniniEH，BrewerEJ，KuzminaN，et ju． [J]．NewEnglJMed，2004，350(25)：2572—2581． of venilerheumatoidarthritis．ResultsoftheUSA—URSS a1．Clinical toeilizumab double—blind，[17]YokotaS，MiyamaeT，lmngawaT，et study trial．ThePediatric inchildrenwith placebo—controlled RheumatologyCollabotative systemic—onsetjuvenfleidiopathic Rev StudyGroupandtheCooperativeChildren’sStudyGroup[J]．Ⅳ凸∥JAlrgyhnmunol，2005，28(3)：231—238． It of label trialsin· Med，1992，326：1043—1049． [18]WooP，WilkinsonN，PrieurAM，eta1．Open phase a1．Arandomizedtrialof dosesofMRAinCaucasianchildrenwi￡Ilsevero [1】]RupertoN，MurrayKJ，GerloniV，et I锄fnteral e．ascending sys- methotrexateanintermediatedosewitha temic of ofthe of comparing juvenile princ：ipie efficacy hi#erdose,in．chil- idiopathicarthritis：proof drenwith arthritiswhofailedto tostanda